Literature DB >> 30302743

Interleukin-1 Receptor-Like 1 (IL1R1) Levels Are Not Increased in Healthy Centenarians.

Lourdes Vicent1, Helena Martínez-Sellés2, Alejandro Lucia3, Enzo Emanuele4, Francisco Fernández-Avilés1,2, Manuel Martínez-Sellés5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30302743     DOI： 10.1007/s12265-018-9838-5

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


× No keyword cloud information.
  5 in total

Review 1.  ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.

Authors:  James L Januzzi; Alexandre Mebazaa; Salvatore Di Somma
Journal:  Am J Cardiol       Date:  2015-01-23       Impact factor: 2.778

Review 2.  Soluble ST2 testing in the general population.

Authors:  Jennifer E Ho; Piyamitr Sritara; Christopher R deFilippi; Thomas J Wang
Journal:  Am J Cardiol       Date:  2015-01-23       Impact factor: 2.778

3.  A panel of multibiomarkers of inflammation, fibrosis, and catabolism is normal in healthy centenarians but has high values in young patients with myocardial infarction.

Authors:  Lourdes Vicent; Helena Martínez-Sellés; Albert Ariza-Solé; Alejandro Lucia; Enzo Emanuele; Antoni Bayés-Genís; Francisco Fernández-Avilés; Manuel Martínez-Sellés
Journal:  Maturitas       Date:  2018-07-19       Impact factor: 4.342

Review 4.  ST2 as a cardiovascular risk biomarker: from the bench to the bedside.

Authors:  James L Januzzi
Journal:  J Cardiovasc Transl Res       Date:  2013-04-05       Impact factor: 4.132

5.  Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.

Authors:  Erin E Coglianese; Martin G Larson; Ramachandran S Vasan; Jennifer E Ho; Anahita Ghorbani; Elizabeth L McCabe; Susan Cheng; Michael G Fradley; Dana Kretschman; Wei Gao; George O'Connor; Thomas J Wang; James L Januzzi
Journal:  Clin Chem       Date:  2012-10-11       Impact factor: 8.327
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.